INTRODUCTION {#sec1-1}
============

Type II diabetes mellitus is commonly known as non-insulin dependent diabetes, and is characterized by hyperglycemia and deficiency of secretion or action of endogenous insulin and associated with a number of vascular and neuropathic complications. In recent years, role of oxidative stress as a cellular mechanism in the pathology of diabetes has been described.\[[@CIT1]--[@CIT3]\] Oxidative stress is involved in the pathogenesis of both types of diabetes mellitus by generation of oxygen free radicals due to nonenzymatic protein glycosylation, auto-oxidation of glucose and also by changing the content of antioxidant defense enzyme.\[[@CIT1][@CIT4]--[@CIT7]\] As diabetes is one of the chronic diseases that is increasing rapidly in the world population, it seems that the screening of new natural sources including plant extracts or compounds for antidiabetic properties is necessary. For many years, various medicinal plants have been used by people in different countries to treat or alleviate diabetes mellitus symptoms and currently studies at basic and clinical levels conducted worldwide have shown these beneficial effects.\[[@CIT8][@CIT9]\] Mechanism of hypoglycemic effect of most of the natural antidiabetic alternatives is thought to be related to the existence of some compounds which stimulate insulin secretion from pancreatic β-cells or possess antioxidant activities.\[[@CIT3][@CIT8]--[@CIT10]\]

A number of *Phlomis* species (Lamiaceae) have been used in folk medicine as stimulants, anticough agents, and to treat gastric, intestinal and abdominal pains, as a tonic, sedative, carminative and astringent.\[[@CIT11]\] Various activities such as antinociceptive,\[[@CIT12][@CIT13]\] antigenotoxic and antioxidant,\[[@CIT14]\] antiulcerogenic, anticancer, anti-inflammatory and antiallergic activities have been reported for some *Phlomis* species.\[[@CIT11]\] This genus is rich in terpenoids, iridoids, flavonoids and other phenolic compounds that contribute potential biological effects like antioxidant activities to many of them. Many of the reports published focused on antioxidant and antimicrobial properties, and the antidiabetic activity of this genus has not been sufficiently investigated.\[[@CIT11][@CIT15]\] A recent study on *Phlomis anisodonta* showed powerful antidiabetic and antioxidant effects in diabetic rats.\[[@CIT16]\] Latest studies on the alcoholic extract of aerial parts of *Phlomis persica*, which is an endemic species in Iran, showed that it contains terpenoids, iridoids, flavonoids, and other related phenolic compounds\[[@CIT17]\] and the free radical scavenging activity of the ethyl acetate extract of *P. persica* on DPPH free radicals may be related to its high phenolic content.\[[@CIT18]\]

Injection of streptozotocin (STZ) in one of the animal models produces diabetes (types I and II diabetes mellitus) by destroying pancreatic β-cells, probably via a free radical mechanism.\[[@CIT19]\] The purpose of this study was to investigate the effects of *P. persica* methanol extract (PPE) on STZ-induced diabetes in rats, by measuring fasting blood glucose, insulin levels, total antioxidant power (TAP), and hepatocellular lipid peroxidation, and the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx).

MATERIALS AND METHODS {#sec1-2}
=====================

Chemicals {#sec2-1}
---------

Glibenclamide from Tehran Chemistry (Tehran, Iran), STZ from Pharmacia and Upjohn (USA), sodium acetate, ethylenediamine tetraacetic acid (EDTA), FeCl~3~.6H~2~O, sodium sulfate, FeSO~4~, potassium dihydrogen phosphate (KH~2~PO~4~), potassium hydrogen diphosphate (K~2~HPO~4~), 2-thiobarbituric acid (TBA), bovine serum albumin (BSA) from Merck (Iran), 2,4,6-tripyridyl-s-triazine (TPTZ), Folin-Ciocalteu reagent, 1,1,3,3-tetramethoxypropan, xanthine, xanthine oxidase (1 U/mg protein from buttermilk), SOD (4400 U/mg protein, from *Escherichia coli*), GSH, GPx, NADPH, glutathione reductase, NaN~3~ from Sigma-Aldrich (England), and nitroblue tetrazolium (NBT) from Acros Organics (USA) were used in this study. Solvents used were of the highest commercial grade.

Plant materials and extraction procedures {#sec2-2}
-----------------------------------------

Aerial parts of *P. persica* (Goosh bareh in Persian) were collected from northeast of Iran (Khorassan province) during the flowering stages. They were identified by Dr. G. Amin and deposited at Herbarium of Faculty of Pharmacy (FP), Tehran University of Medical Sciences (TUMS), with voucher specimen no. 6532 TEH. The air-dried powdered parts (580 g) of P. persica were extracted twice with methanol 80% (2 × 2 l) at 45°C in percolator. The combined methanol extracts were evaporated to dryness under reduced pressure to give solid residues (yield 24%). The residue was stored at 4°C and used for subsequent experiments.\[[@CIT17]\]

Animals and induction of diabetes {#sec2-3}
---------------------------------

Male Wistar rats weighing 220--270 g were obtained from animal house of FP/TUMS. The rats were housed in an air-conditioned room at 25 ± 1°C with a lighting schedule of 12 h light and 12 h dark cycle. A standard pelleted diet and tap water were supplied *ad libitium*. After fasting for 16 h, the rats were injected intraperitoneally (i.p.) with a single dose of 40 mg/kg of STZ freshly dissolved in normal saline. Diabetes in rats was identified by polydipsia, polyuria and by measuring fasting blood glucose concentrations 48 h after the injection of STZ. Rats with a blood glucose level 250--280 mg/dl were selected for the experiments. All the experiments were performed according to "The Animal Welfare Act" (Act P.L. 99-198) and all ethical manners were considered carefully.

Experimental design {#sec2-4}
-------------------

The animals (*n* = 30) were randomly divided into five groups of six animals each as given below. Glibenclamide and different doses of PPE were administered in aqueous solution (3% v/v Tween 80 in water) once per day, using an intragastric tube. The groupings are as follows:

Group I: normal control (aqueous solution)

Group II: diabetic control (aqueous solution)

Group III: diabetic-PPE (100 mg/kg)

Group IV: diabetic-PPE (200 mg/kg)

Group V: diabetic-glibenclamide (3 mg/kg)\[[@CIT16]\]

All the treatments continued for 10 days. On the evening of days 1 and 10, all rats were fasted overnight (16 h) and blood was collected from the tail. Blood samples were centrifuged at 4500 *g* for 10 min to obtain serum. On day 10 of the treatment, rats were anesthetized by administration of pentobarbital (55 mg/kg) and laparotomy was performed. Liver was dissected out and rinsed in ice-cold saline to remove the blood and immediately frozen and stored at −80°C for various assays. Before analyzing, the liver was homogenized in 50 mM phosphate buffer solution (pH 7.4) using a tissue homogenizer at 4°C. The homogenates were centrifuged at 15000 *g* for 20 min and the supernatant was used for analyses.

Analytical procedures {#sec2-5}
---------------------

Blood glucose was measured using glucometer (EasyGluco, infopia Co, Ltd, Korea). Insulin was determined by (Enzyme-Linked ImmunoSorbent Assay) ELISA technique using Mercodia Kit (Sweden). The ability of the samples to reduce Fe^3+^ to Fe^2+^ in ferric reducing antioxidant power (FRAP) method was determined\[[@CIT20]\] as an index of TAP, as described previously by Benzi and Strains. Thiobarbituric acid reactive substances (TBARS) were determined\[[@CIT21]\] as an index of lipid peroxidation by the method of Satho. SOD was quantified according to the method described by Ukeda *et al*.\[[@CIT22]\] CAT was determined by monitoring the decomposition of hydrogen peroxide, as described by Aebi.\[[@CIT23]\] GPx was determined by the method of Paglia and Valentine.\[[@CIT24]\] Protein was determined by the method of Lowry *et al*.,\[[@CIT25]\] using bovine serum albumin as standard.

Statistical analysis {#sec2-6}
--------------------

All data are expressed as mean ± SD. Statistical analysis was performed with one way analysis of variance (ANOVA), followed by Tukey *post hoc* test for multiple comparisons and *P* \< 0.05 was considered significant.

RESULTS {#sec1-3}
=======

Effects of *P. persica* methanol extract on fasting blood glucose, serum insulin and body weight {#sec2-7}
------------------------------------------------------------------------------------------------

[Table 1](#T0001){ref-type="table"} shows the effects of PPE on fasting blood glucose, serum insulin and body weight in normal and experimental rats. There was a significant elevation in blood glucose 48 h after administration of STZ. After 10 days, no significant change in blood glucose was noted in normal rats (Group I), while there was a significant elevation in blood glucose and decrease in serum insulin levels in STZ-induced diabetic rats (Group II). The administration of PPE (Groups III and IV) and glibenclamide (Group V) significantly decreased blood glucose and significantly increased serum insulin levels in diabetic rats as compared with diabetic control rats. The decrease in body weight in PPE-treated and glibenclamide-treated groups was significantly less than that of diabetic control rats.

###### 

Effect of PPE on rat blood glucose and insulin levels, and body weight

  Group                        Glucose (mg/dl)   Insulin (pmol/l)                                   Change in body weight (g)                         
  ---------------------------- ----------------- -------------------------------------------------- ------------------------------------------------- --------------------------------------------------
  Normal                       63.80 ± 5.60      62.17 ± 7.44                                       192.10 ± 8.42                                     63.67 ± 9.58
  Diabetic control             258.17 ± 11.32    295.00 ± 20.49[\*](#T000F1){ref-type="table-fn"}   49.59 ± 7.66[\*](#T000F1){ref-type="table-fn"}    −72.50 ± 12.77[\*](#T000F1){ref-type="table-fn"}
  Diabetic + PPE (100 mg/kg)   262.33 ± 14.92    76.00 ± 3.58[\*](#T000F1){ref-type="table-fn"}     127.71 ± 3.19[\*](#T000F1){ref-type="table-fn"}   −19.33 ± 3.39[\*](#T000F1){ref-type="table-fn"}
  Diabetic + PPE (200 mg/kg)   250.83 ± 8.23     75.00 ± 8.07[\*](#T000F1){ref-type="table-fn"}     133.66 ± 1.49[\*](#T000F1){ref-type="table-fn"}   −17.00 ± 3.29[\*](#T000F1){ref-type="table-fn"}
  Diabetic + glibenclamide     259.67 ± 7.12     76.83 ± 6.62[\*](#T000F1){ref-type="table-fn"}     138.32 ± 9.80[\*](#T000F1){ref-type="table-fn"}   −27.33 ± 5.57[\*](#T000F1){ref-type="table-fn"}

Values are given as the mean ± SD for groups of six animals in each.

Values are statistically significant at *P* \< 0.05.

Diabetic control rats were compared with normal rats, PPE-treated diabetic rats were compared with diabetic control, glibenclamide-treated diabetic rats were compared with diabetic control. PPE, *P. persica* methanolic extract

Effects of *P. persica* methanol extract on liver total antioxidant power {#sec2-8}
-------------------------------------------------------------------------

[Table 2](#T0002){ref-type="table"} summarizes the effects of PPE on liver TAP and lipid peroxidation. There was a significant decrease in TAP of STZ-induced diabetic rats as compared with normal rats. PPE (100 and 200 mg/kg) and glibenclamide treatments significantly increased TAP in diabetic rats, as compared with diabetic control rats. Additionally, doses of 100 and 200 mg/kg of PPE were more effective than glibenclamide in improving TAP of diabetic rats.

###### 

Effect of PPE on rat liver TAP and TBARS

  Group                        TAP (nmol/mg protein)                           TBARS (nmol/mg protein)
  ---------------------------- ----------------------------------------------- -----------------------------------------------
  Normal                       5.22 ± 0.18                                     0.69 ± 0.01
  Diabetic control             1.17 ± 0.09[\*](#T000F2){ref-type="table-fn"}   2.32 ± 0.21[\*](#T000F2){ref-type="table-fn"}
  Diabetic + PPE (100 mg/kg)   3.64 ± 0.49[\*](#T000F2){ref-type="table-fn"}   0.79 ± 0.02[\*](#T000F2){ref-type="table-fn"}
  Diabetic + PPE (200 mg/kg)   3.69 ± 0.01[\*](#T000F2){ref-type="table-fn"}   0.82 ± 0.04[\*](#T000F2){ref-type="table-fn"}
  Diabetic + glibenclamide     2.01 ± 0.16[\*](#T000F2){ref-type="table-fn"}   0.72 ± 0.04[\*](#T000F2){ref-type="table-fn"}

Values are given as mean ± SD for groups of six animals in each.

Values are statistically significant at *P* \< 0.05.

Diabetic control rats were compared with normal rats, PPE-treated diabetic rats were compared with diabetic control, glibenclamide-treated diabetic rats were compared with diabetic control. PPE, *P. persica* methanolic extract

Effects of *P. persica* methanol extract on liver lipid peroxidation {#sec2-9}
--------------------------------------------------------------------

There was a significant elevation in tissue TBARS in diabetic rats as compared with normal rats. Administration of PPE (100 and 200 mg/kg) and glibenclamide significantly decreased lipid peroxidation in liver of diabetic rats and the levels reached near to normal values.

Effects of *P. persica* methanol extract on liver superoxide dismutase, catalase and glutathione peroxidase {#sec2-10}
-----------------------------------------------------------------------------------------------------------

[Table 3](#T0003){ref-type="table"} shows the effects of PPE on liver SOD, CAT and GPx. During diabetes, there was a significant reduction in the activities of SOD, CAT and GPx. PPE (100 and 200 mg/kg) and glibenclamide treatments significantly increased SOD as compared with diabetic control group. Additionally, the effect of PPE (100 and 200 mg/kg) was significantly greater than that of glibenclamide. There was a significant increase in CAT of diabetic rats treated with doses of 100 and 200 mg/kg of PPE and glibenclamide when compared with diabetic control rats. GPx significantly increased in the groups of rats treated with doses of PPE (100 and 200 mg/kg), and glibenclamide as compared with diabetic control rats.

###### 

Effect of PPE on rat liver SOD, CAT and GPx activities

  Group                        SOD (U[a](#T000F4){ref-type="table-fn"}/mg protein)   CAT (U[b](#T000F5){ref-type="table-fn"}/mg protein)   GPx (U[c](#T000F6){ref-type="table-fn"}/mg protein)
  ---------------------------- ----------------------------------------------------- ----------------------------------------------------- -----------------------------------------------------
  Normal                       33.60 ± 3.19                                          74.10 ± 3.26                                          41.92 ± 2.11
  Diabetic control             7.86 ± 1.18[\*](#T000F3){ref-type="table-fn"}         11.18 ± 1.28[\*](#T000F3){ref-type="table-fn"}        9.40 ± 1.72[\*](#T000F3){ref-type="table-fn"}
  Diabetic + PPE (100 mg/kg)   21.32 ± 0.65[\*](#T000F3){ref-type="table-fn"}        35.02 ± 0.76                                          26.90 ± 1.38[\*](#T000F3){ref-type="table-fn"}
  Diabetic + PPE (200 mg/kg)   23.92 ± 0.21[\*](#T000F3){ref-type="table-fn"}        41.0 ± 3.44[\*](#T000F3){ref-type="table-fn"}         26.72 ± 0.78[\*](#T000F3){ref-type="table-fn"}
  Diabetic + glibenclamide     15.90 ± 1.03[\*](#T000F3){ref-type="table-fn"}        50.3 ± 5.78[\*](#T000F3){ref-type="table-fn"}         21.71 ± 1.15[\*](#T000F3){ref-type="table-fn"}

Values are given as the mean ± SD for groups of six animals in each. Values are statistically significant at

*P* \< 0.05. Diabetic control rats were compared with normal rats, PPE-treated diabetic rats were compared with diabetic control, glibenclamide-treated diabetic rats were compared with diabetic control. PPE, *P. persica* methanol extract,

One unit of SOD is defined as the amount of enzyme required to inhibit the rate of NBT reduction by 50%;

one unit of CAT is defined as millimoles of H~2~O~2~ decomposed/min;

one unit of GP× is defined as 1 μmol NADPH oxidized/min

DISCUSSION {#sec1-4}
==========

Type II diabetes is an endocrine dysfunction that is characterized by chronic hyperglycemia and decrease of insulin secretion or incapability of the peripheral tissues to respond to insulin and is usually associated with a loss of weight.\[[@CIT26]\]Animal models of non-insulin dependent diabetes (type II diabetes) could be produced after administering a single mild dose of STZ (40 mg/kg) in the adult rats.\[[@CIT19][@CIT27]\]

This study demonstrated that administration of PPE for 10 days reduces fasting blood glucose and increases the level of insulin in STZ-induced diabetic rats. Moreover, the weight loss recovered by PPE treatment. The present data indicate that glibenclamide reduces blood glucose and increases insulin levels in diabetes, which is consistent with previous studies.\[[@CIT16][@CIT28]\] The possible mechanism by which PPE brings its anti-hyperglycemic action may be through membrane depolarization and stimulation of Ca^2+^ channels influx, like glibenclamide, leading to release of more insulin as recommended by other researchers too.\[[@CIT29][@CIT30]\]Supporting this finding, there are numerous studies showing hypoglycemic effects for some plants that contain iridoids, flavonoids and related phenolic compounds.\[[@CIT8][@CIT31][@CIT32]\] Furthermore, there is evidence showing that some terpenoids and flavonoids stimulate insulin secretion from pancreatic β-cells, possibly by blocking ATP-sensitive potassium and L-type Ca^2+^ channels on pancreatic β-cells\[[@CIT10]\] like glibenclamide,\[[@CIT33]\] activation of the cAMP/PKA signaling,\[[@CIT34]\] and antioxidant activities.\[[@CIT3]\] On the other hand, some flavonoids have been found to inhibit glucose transporters in the intestine,\[[@CIT35]\] increase the storage of glucose in the liver (up-regulated glycogenesis) and reduce glycogen breakdown.\[[@CIT36]\]

Phytochemical study of PPE has shown that it contains terpenoids, iridoids, flavonoids and other phenolic compounds.\[[@CIT17][@CIT18]\] These components may then be responsible for antihyperglycemic effect of PPE observed in the present investigation. Loss of body weight has been related to diabetes mellitus. Observations of this study showed that the PPE-treated and glibenclamide-treated groups significantly ameliorated the weight loss than that of diabetic control rats.

The increase in oxygen free radicals in diabetes could be related to rise in blood glucose levels, leading to auto-oxidation to generate free radicals.\[[@CIT1][@CIT9]\] Increased concentration of TBARS and decreased level of TAP were observed in liver tissue during diabetes. In this study, hepatic TAP significantly increased and TBARS decreased following PPE treatment, similar to glibenclamide-treated group. Lipid peroxide-mediated tissue damage has been observed in the development of diabetes mellitus. Elevated level of lipid peroxidation in tissues of STZ-induced diabetic rats is one of the characteristic features of chronic diabetes.\[[@CIT30][@CIT33]\] In diabetes, it is thought that hypoinsulinemia increases the activity of the enzyme, fatty acyl coenzyme A oxidase, which initiates β-oxidation of fatty acids, resulting in lipid peroxidation. The increase of lipid peroxidation levels causes functional impairment of membrane by decreasing membrane fluidity and through changing the activity of membrane-bound enzymes and receptors.\[[@CIT37]\] Lipid peroxidation will in turn result in elevated production of free radicals that are harmful to cells in the body.\[[@CIT3]\]

The present data also show that STZ-induced diabetes disturbs actions of hepatic antioxidant enzymes (SOD, CAT and GPx). The decreased activities of SOD, CAT and GPx in liver during diabetes mellitus may be due to the production of reactive oxygen free radicals that can themselves reduce the activity of these enzymes.\[[@CIT33][@CIT38]\] These enzymes could destroy the peroxides and play a significant role in providing antioxidant defenses to an organism. In the enzymatic antioxidant defense system, SOD and CAT are the two important scavenging enzymes that remove superoxide radicals (O~2~^.^) and hydrogen peroxide, respectively, *in vivo*. Decrease in GPx activity was also observed in tissues during diabetes. GPx plays a main role in minimizing oxidative damage and is known to be involved in the elimination of low H~2~O~2~ concentrations, whereas CATissensitive to higher concentrations of H~2~O~2~.\[[@CIT6][@CIT38][@CIT39]\] Decrease in SOD, CAT and GPx activities may be due to inadequacy of antioxidant defenses in combating reactive oxygen species (ROS) production.\[[@CIT30]\] The positive effect of PPE on these antioxidant enzymes is most probably due to the existence of iridoid glycosides, flavonoids and other phenolic compounds in PPE,\[[@CIT17][@CIT18]\] as well-known antioxidants\[[@CIT8][@CIT40][@CIT41]\] which scavenge the free radicals generated during diabetes.

The present findings support recent report about positive effects of *P. anisodonta* in experimental diabetes\[[@CIT16]\] and provide some valuable insight into the hypoglycemic potency of *P. persica* in STZ-induced diabetes. In addition, it is concluded that antidiabetic effect of PPE may be related to its potential to inhibit hepatocellular oxidative stress. However, we believe that *P. persica* should be considered as a good candidate like *P. anisodonta* for further investigations to identify the responsible isolated components for antidiabetic effect.
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